Barriers to Medication Adherence and Mild Cognitive Impairment Among African Americans with Persistently Uncontrolled Hypertension: A Cross-sectional Analysis from the Southeastern Collaboration Trial - Summary - MDSpire
Advertisement
Barriers to Medication Adherence and Mild Cognitive Impairment Among African Americans with Persistently Uncontrolled Hypertension: A Cross-sectional Analysis from the Southeastern Collaboration Trial
To explore the association between specific barriers to medication adherence (e.g., forgetfulness, cost, complexity) and the presence of mild cognitive impairment (MCI) in African American patients with uncontrolled hypertension.
Key Findings:
A significant association was found between barriers to medication adherence and the presence of MCI.
As the number of adherence barriers increased, the odds of MCI also increased.
Participants with multiple barriers to adherence had worse cognitive outcomes, indicating a potential cumulative effect.
Interpretation:
The findings suggest that assessing barriers to medication adherence could serve as an early indicator of cognitive impairment, highlighting the need for comprehensive cognitive assessments in patients with hypertension to improve management strategies.
Limitations:
The study was limited to a specific demographic (African American patients in rural areas), which may affect generalizability to other populations.
The SIS has moderate sensitivity, which may lead to underdiagnosis of MCI, potentially skewing the association with medication adherence.
Conclusion:
Identifying barriers to medication adherence may provide a valuable strategy for early detection of cognitive impairment in patients with uncontrolled hypertension, potentially guiding more aggressive management of cognitive risk factors.
